(Q41666648)

6 October 2017

Age-related blunting of growth hormone secretion during exercise may not be soley due to increased somatostatin tone (English)

1 reference

6 October 2017

Marcell TJ

1

1 reference

6 October 2017

Wiswell RA

series ordinal

2

1 reference

6 October 2017

Hawkins SA

series ordinal

3

1 reference

6 October 2017

Tarpenning KM

series ordinal

4

1 reference

6 October 2017

1 May 1999

1 reference

6 October 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

6 October 2017

48

1 reference

6 October 2017

5

1 reference

6 October 2017

665-670

1 reference

Testosterone, growth hormone and IGF-I responses to acute and chronic resistive exercise in men aged 55-70 years

6 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Gender differences in secretory activity of the human somatotropic (growth hormone) axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Opioid modulation of the gamma-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Impaired growth hormone secretion in the adult population: relation to age and adiposity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Metabolic clearance and production rates of human growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Somatostatin tonically inhibits growth hormone secretion in domestic fowl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Effect of aging on changes in plasma potassium during exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Influence of pyridostigmine on growth hormone (GH) response to GH-releasing hormone pre- and postprandially in normal and obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Acute hormonal responses to heavy resistance exercise in men and women at different ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Oral arginine does not stimulate basal or augment exercise-induced GH secretion in either young or old adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Cholinergic and opioid involvement in release of growth hormone during exercise and recovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

Changes in cardiovascular function with aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990069-0

10.1016/S0026-0495(99)90069-0

7 January 2021

Identifiers

DOI

1 reference

6 October 2017

1 reference